• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病运动前人体测量和血清学标志物的纵向分析。

Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease.

机构信息

Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Kumiai Kosei Hospital, Takayama, Gifu, 5068502, Japan.

出版信息

Sci Rep. 2020 Nov 25;10(1):20524. doi: 10.1038/s41598-020-77415-1.

DOI:10.1038/s41598-020-77415-1
PMID:33239649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7688961/
Abstract

Parkinson's disease (PD) is a debilitating neurodegenerative disorder in which nonmotor symptoms, such as constipation and hyposmia, precede the onset of motor symptoms by 20 years. The aim of this study was to identify biomarkers at the premotor stage of PD. We assessed the differences in longitudinal changes in anthropometric and serological indices obtained from health check-up data before and after the onset of motor symptoms between male and female PD patients and healthy subjects. We enrolled 22 male and 23 female PD patients and 60 male and 60 female healthy controls. A mixed-effects model was used to estimate the trajectory of each clinical marker over the years before and after motor symptoms onset in the PD subjects, which were then compared with the trajectories of the healthy controls. The results showed a premotor blood pressure increase in female PD patients and premotor decreases in haematocrit, total cholesterol and low-density lipoprotein cholesterol in the male patients. Our results indicated that blood pressure, haematocrit and serum cholesterol levels are potential premotor markers of PD. Additionally, the changes in anthropometric and serological indices before PD motor symptoms onset were sex specific.

摘要

帕金森病(PD)是一种使人衰弱的神经退行性疾病,其非运动症状,如便秘和嗅觉减退,在运动症状出现前 20 年就已经出现。本研究旨在确定 PD 运动前期的生物标志物。我们评估了男性和女性 PD 患者以及健康受试者在运动症状出现前后,从健康检查数据中获得的人体测量和血清学指标的纵向变化差异。我们纳入了 22 名男性和 23 名女性 PD 患者,以及 60 名男性和 60 名女性健康对照者。采用混合效应模型来估计 PD 患者在运动症状出现前后几年中每个临床标志物的轨迹,然后将这些轨迹与健康对照者的轨迹进行比较。结果显示,女性 PD 患者出现了运动前期的血压升高,而男性患者则出现了运动前期的血细胞比容、总胆固醇和低密度脂蛋白胆固醇降低。我们的研究结果表明,血压、血细胞比容和血清胆固醇水平可能是 PD 的运动前期生物标志物。此外,PD 运动症状出现前的人体测量和血清学指标的变化具有性别特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/60ce1c7f37d2/41598_2020_77415_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/debd2fa888ed/41598_2020_77415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/05ecd4a881fd/41598_2020_77415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/60ce1c7f37d2/41598_2020_77415_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/debd2fa888ed/41598_2020_77415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/05ecd4a881fd/41598_2020_77415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55b6/7688961/60ce1c7f37d2/41598_2020_77415_Fig3_HTML.jpg

相似文献

1
Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease.帕金森病运动前人体测量和血清学标志物的纵向分析。
Sci Rep. 2020 Nov 25;10(1):20524. doi: 10.1038/s41598-020-77415-1.
2
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).帕金森病非运动症状的发病(ONSET PD 研究)。
Mov Disord. 2015 Feb;30(2):229-37. doi: 10.1002/mds.26077. Epub 2014 Dec 1.
3
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.帕金森病运动前期标志物的评估:运动前期标志物研究。
Neuroepidemiology. 2013;41(3-4):174-82. doi: 10.1159/000353560. Epub 2013 Sep 17.
4
Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.运动前症状与帕金森病风险:墨西哥人群的病例对照研究
Clin Neurol Neurosurg. 2017 Sep;160:46-49. doi: 10.1016/j.clineuro.2017.06.010. Epub 2017 Jun 15.
5
Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.帕金森病风险个体的 RNA 血液生物标志物评估。
J Parkinsons Dis. 2017;7(4):653-660. doi: 10.3233/JPD-171155.
6
Risk of premotor symptoms in patients with newly diagnosed PD: a nationwide, population-based, case-control study in Taiwan.新诊断帕金森病患者运动前症状的风险:台湾一项基于全国人群的病例对照研究
PLoS One. 2015 Jun 24;10(6):e0130282. doi: 10.1371/journal.pone.0130282. eCollection 2015.
7
Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.在帕金森病患者进行外部节奏运动时,左旋多巴可恢复前额叶到运动前区皮质的连接。
Neuroimage. 2014 Apr 15;90:15-23. doi: 10.1016/j.neuroimage.2013.11.023. Epub 2013 Nov 22.
8
Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.新发帕金森病中运动前区-运动区连接的异常兴奋性
Brain. 2004 Dec;127(Pt 12):2732-46. doi: 10.1093/brain/awh321. Epub 2004 Oct 27.
9
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.帕金森进展标志物倡议(PPMI)中无明显 LRRK2 和 GBA 突变携带者的临床和多巴胺转运体成像特征:一项横断面研究。
Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.
10
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).帕金森病队列研究(DeNoPa)中帕金森病确诊后 4 年进展的基线预测因子。
Mov Disord. 2019 Jan;34(1):67-77. doi: 10.1002/mds.27492. Epub 2018 Nov 23.

本文引用的文献

1
Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study.体检人群中帕金森病高危人群:NaT-PROBE 研究基线数据分析的横断面研究。
J Neurol. 2020 May;267(5):1516-1526. doi: 10.1007/s00415-020-09714-6. Epub 2020 Feb 7.
2
The Impact of Estrogen Supplementation to Autonomic and Sleep Modulations in Free-Moving Spontaneously Hypertensive Rats.雌激素补充对自由活动的自发性高血压大鼠自主神经和睡眠调节的影响。
Int Heart J. 2020 Jan 31;61(1):128-137. doi: 10.1536/ihj.19-297. Epub 2020 Jan 17.
3
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
遗传性额颞叶痴呆患者血清神经丝轻链:一项纵向、多中心队列研究。
Lancet Neurol. 2019 Dec;18(12):1103-1111. doi: 10.1016/S1474-4422(19)30354-0.
4
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.血清神经丝动态预测无症状阿尔茨海默病的神经退行性变和临床进展。
Nat Med. 2019 Feb;25(2):277-283. doi: 10.1038/s41591-018-0304-3. Epub 2019 Jan 21.
5
Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.血清胆固醇水平升高与帕金森病风险降低相关:一项无他汀类药物队列研究。
Mov Disord. 2018 Aug;33(8):1298-1305. doi: 10.1002/mds.27413. Epub 2018 Aug 25.
6
Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy.基于生物标志物的脊髓性肌萎缩症和延髓性肌萎缩症临床前进展分析。
Neurology. 2018 Apr 24;90(17):e1501-e1509. doi: 10.1212/WNL.0000000000005360. Epub 2018 Mar 23.
7
Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics.帕金森病的性别差异:临床症状、治疗结果、性激素和遗传学特征。
Front Neuroendocrinol. 2018 Jul;50:18-30. doi: 10.1016/j.yfrne.2017.09.002. Epub 2017 Sep 30.
8
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.脂质与α-突触核蛋白相互作用在帕金森病发病机制中的作用
J Parkinsons Dis. 2017;7(3):433-450. doi: 10.3233/JPD-171103.
9
The treatment of iron deficiency without anaemia (in otherwise healthy persons).缺铁但无贫血(在其他方面健康的人群中)的治疗。
Swiss Med Wkly. 2017 Jun 14;147:w14434. doi: 10.4414/smw.2017.14434. eCollection 2017.
10
Poly(GP) proteins are a useful pharmacodynamic marker for -associated amyotrophic lateral sclerosis.聚(GP)蛋白是与肌萎缩侧索硬化症相关的一种有用的药效学标志物。
Sci Transl Med. 2017 Mar 29;9(383). doi: 10.1126/scitranslmed.aai7866.